Nutraceuticals behind choline demand, says Spanish producer
‘Choline salt specialist Algry Quimica has indicated that demand for its choline derivatives is continuing to rise thanks to growing awareness of their uses in nutraceuticals.
The private Spanish company has said it expects its sales of pharma grade choline salts to increase by between eight and 10 per cent in the first quarter of 2006, compared with the same period last year.
Its portfolio includes pharmaceutical-grade choline chloride (vitamin B4) and choline bitartrate, both of which are used in nutraceuticals, and several new products are in the pipeline for later in the year. Over the next two years it is also planning investment in its Huelva manufacturing facility.’
Read more at Nutraceuticals behind choline demand, says Spanish producer
Recent Entries
- Sigma Pharmaceuticals year profit rises 27 pct
- South African citizens cheap drug guinea pigs
- Two drugs test victims face a year in coma
- Can drug companies improve their reputation?
- Pfizer Sees 40 Percent Rise in 2006 Net on Cost Cuts
- Pfizer’s Forecast Disappoints
- Pharmaceutical RFID Adoption Stalls
- Inhalable Drug Might Bring Sigh Of Relief To Diabetes Patients
- GlaxoSmithKline unveils best results since merger
- Pfizer Sues Teva, Sandoz Over Zithromax